Skip to content
Health

Penn reaped at least $1.6 billion in royalties from the Pfizer-BioNTech COVID-19 vaccine. Now the university is suing for more.

The federal civil lawsuit alleges that the German drugmaker BioNTech did not pay Penn its full share of royalties from worldwide vaccine sales.

The first doses of the Pfizer-BioNTech COVID-19 vaccine were delivered to Penn Medicine's Pennsylvania Hospital Tuesday, Dec. 15, 2020.
The first doses of the Pfizer-BioNTech COVID-19 vaccine were delivered to Penn Medicine's Pennsylvania Hospital Tuesday, Dec. 15, 2020.Read morePenn Medicine